Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Mersana Therapeutics Price to Sales Ratio 2016-2019 | MRSN

Historical PS ratio values for Mersana Therapeutics (MRSN) over the last 10 years. The current P/S ratio for Mersana Therapeutics as of December 09, 2019 is .
  
Mersana Therapeutics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-12-09 4.23 3.07
2019-09-30 1.58 $1.38 1.15
2019-06-30 4.05 $1.45 2.79
2019-03-31 5.26 $1.63 3.22
2018-12-31 4.08 $0.46 8.85
2018-09-30 10.00 $0.68 14.69
2018-06-30 17.86 $0.87 20.53
2018-03-31 15.77 $3.33 4.74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.203B $0.011B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.902B 16.00
CSL (CSLLY) Australia $87.394B 0.00
Gilead Sciences (GILD) United States $84.866B 10.51
Vertex Pharmaceuticals (VRTX) United States $57.409B 58.60
Biogen (BIIB) United States $54.179B 9.30
Illumina (ILMN) United States $47.991B 52.66
Regeneron Pharmaceuticals (REGN) United States $40.872B 17.90
Alexion Pharmaceuticals (ALXN) United States $25.203B 12.45
Incyte (INCY) United States $20.351B 47.24
Seattle Genetics (SGEN) United States $20.138B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.356B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.798B 0.00
Galapagos (GLPG) Belgium $11.704B 30.16
Exact Sciences (EXAS) United States $11.197B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.429B 30.74
BeiGene (BGNE) Cayman Islands $8.976B 0.00
Bio-Techne Corp (TECH) United States $8.358B 55.95
Sarepta Therapeutics (SRPT) United States $8.159B 0.00
Amarin (AMRN) Ireland $8.019B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.917B 0.00
Guardant Health (GH) United States $6.947B 0.00
Medicines (MDCO) United States $6.714B 0.00
Moderna (MRNA) United States $6.312B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.037B 15.35
Reata Pharmaceuticals (RETA) United States $6.034B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.618B 0.00
BioNTech SE (BNTX) Germany $5.514B 0.00
Exelixis (EXEL) United States $5.275B 14.84
Repligen (RGEN) United States $4.701B 85.19
China Biologic Products (CBPO) China $4.603B 25.93
Ascendis Pharma (ASND) Denmark $4.532B 0.00
Bluebird Bio (BLUE) United States $4.394B 0.00
Spark Therapeutics (ONCE) United States $4.263B 0.00
MorphoSys AG (MOR) Germany $4.153B 0.00
Mirati Therapeutics (MRTX) United States $4.047B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.995B 0.00
Immunomedics (IMMU) United States $3.981B 0.00
Blueprint Medicines (BPMC) United States $3.861B 0.00
Adaptive Biotechnologies (ADPT) United States $3.613B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.518B 0.00
Alkermes (ALKS) Ireland $3.300B 0.00
MyoKardia (MYOK) United States $3.117B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
UniQure (QURE) Netherlands $2.881B 0.00
Emergent Biosolutions (EBS) United States $2.838B 28.19
Halozyme Therapeutics (HALO) United States $2.808B 0.00
NeoGenomics (NEO) United States $2.779B 147.89
Acceleron Pharma (XLRN) United States $2.648B 0.00
Amicus Therapeutics (FOLD) United States $2.576B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.484B 0.00
Arena Pharmaceuticals (ARNA) United States $2.408B 5.60
Zai Lab (ZLAB) China $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Insmed (INSM) United States $2.064B 0.00
Myriad Genetics (MYGN) United States $1.905B 28.14
Ligand Pharmaceuticals (LGND) United States $1.897B 36.49
Dicerna Pharmaceuticals (DRNA) United States $1.822B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.782B 0.00
Denali Therapeutics (DNLI) United States $1.754B 0.00
Epizyme (EPZM) United States $1.659B 0.00
Akcea Therapeutics (AKCA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
REGENXBIO (RGNX) United States $1.647B 0.00
Editas Medicine (EDIT) United States $1.586B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.402B 0.00
Athenex (ATNX) United States $1.376B 0.00
Alector (ALEC) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.352B 0.00
Innoviva (INVA) United States $1.308B 3.85
Arvinas (ARVN) United States $1.297B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Principia Biopharma (PRNB) United States $1.226B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.151B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.109B 0.00
Zealand Pharma (ZEAL) Denmark $1.046B 0.00
Fate Therapeutics (FATE) United States $1.033B 0.00
Precision BioSciences (DTIL) United States $0.998B 0.00
Pharming Group (PHGUF) Netherlands $0.968B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.934B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.932B 7.83
Codexis (CDXS) United States $0.909B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 310.50
MiMedx (MDXG) United States $0.821B 0.00
Anika Therapeutics (ANIK) United States $0.820B 26.61
Twist Bioscience (TWST) United States $0.813B 0.00
Heska (HSKA) United States $0.749B 191.46
Adverum Biotechnologies (ADVM) United States $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.718B 12.25
DBV Technologies S.A (DBVT) France $0.717B 0.00
UROGEN PHARMA (URGN) United States $0.685B 0.00
Cara Therapeutics (CARA) United States $0.671B 0.00
Mesoblast (MESO) Australia $0.665B 0.00
Cellectis S.A (CLLS) France $0.623B 0.00
GENFIT S.A (GNFT) France $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.593B 13.72
Autolus Therapeutics (AUTL) United Kingdom $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Kadmon Holdings (KDMN) United States $0.584B 0.00
Sorrento Therapeutics (SRNE) United States $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.576B 0.00
PHARMA MAR SA (PHMMF) Spain $0.570B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.564B 0.00
Cytokineticsorporated (CYTK) United States $0.557B 0.00
Agenus (AGEN) United States $0.537B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.518B 3.58
Stemline Therapeutics (STML) United States $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Bellus Health (BLU) Canada $0.402B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.337B 8.43
Pfenex (PFNX) United States $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.325B 0.00
Starpharma Holdings (SPHRY) Australia $0.320B 0.00
Puma Biotechnology (PBYI) United States $0.307B 0.00
Kindred Biosciences (KIN) United States $0.303B 0.00
Geron (GERN) United States $0.302B 0.00
Kamada (KMDA) Israel $0.297B 8.67
CytomX Therapeutics (CTMX) United States $0.286B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Cel-Sci (CVM) United States $0.273B 0.00
Cue Biopharma (CUE) United States $0.269B 0.00
Albireo Pharma (ALBO) United States $0.264B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Scholar Rock Holding (SRRK) United States $0.252B 0.00
MannKind (MNKD) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.228B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
XOMA (XOMA) United States $0.223B 0.00
Theratechnologies (THTX) Canada $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
Protagonist Therapeutics (PTGX) United States $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Senesco Technologies (ELOX) United States $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
IVERIC Bio (ISEE) United States $0.183B 0.00
Palatin Technologies (PTN) United States $0.182B 4.96
Proteostasis Therapeutics (PTI) United States $0.182B 0.00
Cerecor (CERC) United States $0.176B 0.00
Affimed (AFMD) Germany $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Alcobra (ARCT) United States $0.162B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.156B 0.00
NantKwest (NK) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.149B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Fortress Biotech (FBIO) United States $0.141B 0.00
Aptinyx (APTX) United States $0.139B 0.00
TELA Bio (TELA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Arbutus Biopharma (ABUS) Canada $0.130B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nicox SA (NICXF) France $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.117B 0.00
BioTime (LCTX) United States $0.117B 6.01
Novavax (NVAX) United States $0.116B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.098B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.092B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Orgenesis (ORGS) United States $0.044B 2.83
Celldex Therapeutics (CLDX) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Apricus Biosciences (SEEL) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Signal Genetics (MGEN) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00